Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.
Research Interests

Papers共 29 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Data from first-in-human study of EXS21546, an A2A receptor antagonist, now progressing into phase 1 in RCC/NSCLC
Nieves Diaz, Holly Garratt, Aleksandra Zemla-Brown, Maria Dominguez,Eric Helmer,Isabella Alt,Robert Sehlke, Norbert Hieger, Thomas Winkler-Penz,Christophe Boudesco,Gregory Vladimer, Tom Wilde,
CANCER RESEARCHno. 8 (2023): CT114-CT114
Cited0Views0Bibtex
0
0
2289P Determining anti-cancer efficacy of a reversible LSD1 inhibitor, EXS74539, in primary AML tissues with limited thrombocytopenic effects
C. Boudesco, R. Okumura, M. lautizi, N. Hieger, V. Thatikonda, M. Ssenekowitsch, T-Y. Lin, G. Fiume, R. Sehlke, T. Winkler-Penz,A. Payne,R. Paveley,
Annals of Oncology (2023): S1173-S1173
Cited0Views0Bibtex
0
0
Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning
Isabella Alt, Robert Shelke, Anna Lobley,Claudia Baumgaertler,Maja Stulic,Pierre Fons,Mark Whittaker,Klaus Hackner, Lucia Dzurillova, Edga Petru, Laudia Hadjari,Judith Lafleur,
Cancer Researchno. 12_Supplement (2022): 4150-4150
Cited0Views0Bibtex
0
0
23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material
G. Vladimer, I. Alt, R. Sehlke, A. Lobley, C. Baumgärtler, M. Stulic, K. Hackner, L. Dzurillova,E. Petru, L. Hadjari,J. Lafleur, J. Singer,
Immuno-Oncology and Technology (2022): 100128
Cited1Views0Bibtex
1
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn